Theravance Biopharma, Inc.
Status: Publicly traded
Direct answer
Theravance Biopharma, Inc. is publicly traded on NASDAQ under the ticker TBPH.
Theravance Biopharma, Inc. is a biopharmaceutical firm focused on discovering, developing, and bringing to market treatments for respiratory conditions across North America, Europe, and Asia. Its portfolio features YUPELRI, a daily, nebulized long-acting muscarinic antagonist (LAMA) prescribed for chronic obstructive pulmonary disease (COPD). The company also maintains a substantial pipeline of experimental...
Can you invest in Theravance Biopharma, Inc.?
Yes. Theravance Biopharma, Inc. is publicly traded on NASDAQ under the ticker TBPH.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Theravance Biopharma, Inc.
Detailed equity research is provided by MarketSnap.